TC BioPharm (AgeTech UK) Covid-19

Cancer and infectious diseases, gamma delta T cell therapies. Developing safer, less expensive CAR-T products which can target more cancers.
Investors
Technology:
AgeTech Companies
Industry:
UK AgeTech 2020
Headquarters:
United Kingdom
Founded Date:
N/A
Employees Number:
N/A
Funding Status:
N/A
Register and Claim Ownership